Title: An open label 3-arm randomised phase 2 study to compare the safety and efficacy of ponatinib in combination with either chemotherapy or blinatumomab

Amgen Ltd

Principal Investigator

Thomas, Ian

Project Details
Net value award figure for Cardiff University: £1,564,590.00
Start date: 01/01/2019
End date: 31/12/2025

Last updated on 2020-25-10 at 06:01